Understanding the Legal and Ethical Challenges AI Poses in Oncology
The field of oncology is undergoing a transformation, driven by the rapid integration of artificial intelligence (AI) technology. These advancements promise unprecedented improvements in cancer detection, personalized treatment strategies, and patient support. However, as the integration of AI into oncology progresses, a myriad of legal and ethical challenges emerges.
AI in Diagnosis and Treatment
AI tools have been instrumental in enhancing the analysis of medical imaging data, such as MRI scans, CT scans, and mammograms. These algorithms are adept at identifying subtle patterns that might elude human observation, potentially leading to faster and more accurate cancer detection. AI also plays a crucial role in treatment delivery and decision-making, particularly in radiation therapy and immunotherapy regimen design.
Yet, the use of AI in diagnosis raises significant legal questions. Traditionally, human physicians are not held strictly liable for incorrect diagnoses or treatments if their conduct meets the standard of care. However, defining a legal standard for AI-related errors remains uncertain. Some propose a strict liability standard, holding manufacturers accountable for defects without needing to prove fault, while others suggest alternative product liability standards.
Legal Standards and Liability
The complexity of applying legal standards to AI tools is compounded by their evolving nature. AI algorithms often change as they process more data, challenging traditional product liability frameworks. Different jurisdictions are adopting varied approaches to liability, with the European Commission discussing a proposed AI Liability Directive for high-risk AI systems.
Patient Counseling and Ethical Considerations
Beyond diagnostics, AI is also being explored for patient counseling. Studies have evaluated the use of AI chatbots for cancer-related inquiries, with mixed results. While these chatbots can provide helpful information, they are not yet fully ready for patient-facing roles. A recent study found that AI chatbots were as effective as human counselors in educating breast cancer patients about genetic dimensions, suggesting potential in freeing up human resources for more intensive counseling.
However, using AI in patient counseling introduces critical ethical issues, particularly regarding data security and informed consent. Patients must be aware they are receiving advice from an AI system, and there must be safeguards against harmful advice.
Future Directions and Challenges
The integration of AI into oncology presents long-term challenges, including ensuring that AI enhances rather than diminishes professional skills. Oncology professionals must be trained to effectively use AI tools, much like adapting to electronic medical records in previous eras.
In conclusion, while AI offers promising advancements in oncology, its legal and ethical implications are evolving and uncertain. Understanding these complexities is crucial to ensuring that AI serves as a tool to augment human expertise and improve patient outcomes. For more details, refer to the original article on The ASCO Post.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
The commercial real estate sector closed out 2025 with renewed stability, as the Real Estate Roundtable’s latest sentiment index shows rising confidence and improving market fundamentals. Executives report better access to capital, stronger performance in residential, retail, and hospitality, and early signs of recovery in the office market. With financing loosening and asset values climbing, the outlook for 2026 is increasingly optimistic, creating fresh opportunities for both seasoned professionals and newcomers preparing to enter the field.
The CFPB is proposing changes to how lenders evaluate “disparate impact” under the Equal Credit Opportunity Act, potentially tightening the scrutiny on credit decisions that unintentionally disadvantage protected groups. These updates could reshape underwriting models, lending criteria, and compliance requirements — ultimately influencing mortgage approvals, buyer qualifications, and day‑to‑day real estate activity.
Florida’s insurance crisis has become the defining issue heading into 2026, with Republicans touting recent market improvements while Democrats argue families are still being crushed by soaring premiums. From billion‑dollar auto insurance refunds to condo markets destabilized by post‑Surfside rate spikes, the state’s political divide is shaping the future of real estate, insurance, and affordability for millions.
October 2025 brought a wave of major regulatory updates across insurance, finance, and compliance. From stricter oversight on retail insurers and new FCA rules on ESG and travel insurance, to EIOPA’s EU‑wide consultations and refreshed corporate governance standards, regulators signaled higher expectations and faster change ahead. For professionals—and those pursuing licenses—these shifts directly impact risk management, product design, and consumer outcomes, making regulatory awareness a critical competitive advantage.
After nearly two years of sluggish activity, commercial real estate lending is finally accelerating—fast. New data from CBRE shows loan closings jumped 112% year‑over‑year in Q3 2025, reaching their highest level since 2018. With interest rates stabilizing and credit spreads tightening, investors are returning, banks are re‑entering the market, and multifamily financing is dominating once again. The long‑stalled deal flow is thawing, signaling renewed momentum heading into 2026.
Farmers Insurance is lifting its cap on new homeowner policies in California after two years of limiting growth, signaling a shift in the state’s strained insurance market. The expansion comes with a proposed 6.99 percent rate increase that still needs regulatory approval. Supporters call it a turning point driven by new wildfire‑risk rules, while consumer advocates warn the reforms contain loopholes and could lead to higher costs for homeowners.
Legal Standards and Liability
The complexity of applying legal standards to AI tools is compounded by their evolving nature. AI algorithms often change as they process more data, challenging traditional product liability frameworks. Different jurisdictions are adopting varied approaches to liability, with the European Commission discussing a proposed 
